Abstract
In conventional in vitro tests, bacteria are exposed to a constant concentration of antibiotic throughout the period of the test, and in the case of β-lactam/β-lactamase inhibitor combinations the concentrations of each component will be fixed. This does not reflect the situation in man, where the concentrations of antibiotic and inhibitor in the serum and tissues will be constantly changing according to absorption and elimination rates and any metabolism of the compounds. In vitro kinetic models can be used to simulate the concentrations of antibiotics measured in the serum and extravascular fluid of man following conventional dosage and to assess their antibacterial activities. In these studies, in vitro kinetic models have been used in various ways to assess the bactericidal activities of β-lactam/β-lactamase inhibitor combinations. Straightforward comparative studies can be carried out using different antibiotics; comparisons between different β-lactams and β-lactamase inhibitors; studies to look at concentrations of inhibitor required for different pathogens; and, interaction studies to look for synergy or antagonism can be carried out using these models. Examples of all these types of experiment are described below.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
S. Grasso, G. Meinardi, I. deCarneri, and V. Tamassia, New In Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial Activity. Antimicrobial Agents and Chemother. 13:570–576 (1978).
S.M. Harding, P.E.O. Williams, and J. Ayrton, Pharmacology of Cefuroxime as the 1-Acetoxyethyl ester in Volunteers, Antimicrob. Agents and Chemother. 25, 1:78–82 (1984).
A. Glynne, R.A. Gouldbourn, and R. Ryden, A Human Pharmacology Study of Cefaclor, J. Antimicrob. Chemother. 4:343–348 (1978).
G. Foulds, Pharmacokinetics of Sulbactam and Ampicillin in Humans — A Review. Reviews of Infect. Diseases 8. 5:S503–511 (1986).
D.H. Staniforth, P.E. Coates, B.E. Davies, and R. Horton, Pharmacokinetics of Parenteral Ticarcillin Formulated with Clavulanic Acid — Timentin, Int. J. Clin. Pharm. Ther. and Toxic. 24, 3:123–129 (1986).
S.J. Cavaleiri, C.C. Sanders, and C. New, Influence of β-Lactamase Inhibitors on the Potency of Their Companion Drug with Organisms Possessing Class I Enzymes. Antimicrob. Agents and Chemother. 35, 7:1343–1347 (1991).
A.R. White, D.H. Stokes, B. Slocombe, and R. Sutherland, Bactericidal Effects of Amoxycillin/Clavulanic Acid and Ticarcillin/Clavulanic Acid in In Vitro Kinetic Models, J. Antimicrob. Chemother. 15, A:227–232 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thorburn, C.E., Slocombe, B. (1994). The Use of In-Vitro Kinetic Models in the Evaluation of β-Lactam/β-Lactamase Inhibitor Combinations. In: Poupard, J.A., Walsh, L.R., Kleger, B. (eds) Antimicrobial Susceptibility Testing. Advances in Experimental Medicine and Biology, vol 349. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9206-5_16
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9206-5_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9208-9
Online ISBN: 978-1-4757-9206-5
eBook Packages: Springer Book Archive